Lexagene Stock Today

LXG Stock  CAD 0.27  0.01  3.57%   
Market Performance
3 of 100
Odds Of Distress
Less than 26
Lexagene Holdings is selling for under 0.27 as of the 30th of January 2023; that is -3.57 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.27. Lexagene Holdings has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Lexagene Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of July 2022 and ending today, the 30th of January 2023. Click here to learn more.
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in clinical and life sciences industries. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts. The company has 140.64 M outstanding shares of which 59.08 K shares are now shorted by private and institutional investors with about 1.44 days to cover all short positions. More on Lexagene Holdings
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Lexagene Holdings Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lexagene Holdings' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lexagene Holdings or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman of the Board, CEOJohn Regan
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Lexagene Holdings' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Lexagene Holdings (LXG) is traded on TSX Venture Exchange in Canada and employs 33 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lexagene Holdings's market, we take the total number of its shares issued and multiply it by Lexagene Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lexagene Holdings classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 140.64 M outstanding shares of which 59.08 K shares are now shorted by private and institutional investors with about 1.44 days to cover all short positions. Lexagene Holdings has accumulated about 1.34 M in cash with (9.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Lexagene Holdings Probability Of Bankruptcy
Ownership
Lexagene Holdings holds a total of 140.64 Million outstanding shares. Lexagene Holdings secures 17.8 % if its outstanding shares held by insiders and 17.8 % owned by institutional investors . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation

Check Lexagene Ownership Details

Lexagene Holdings Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Lexagene Holdings market risk premium is the additional return an investor will receive from holding Lexagene Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lexagene Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Lexagene Holdings' alpha and beta are two of the key measurements used to evaluate Lexagene Holdings' performance over the market, the standard measures of volatility play an important role as well.

Lexagene Stock Against Markets

Picking the right benchmark for Lexagene Holdings stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lexagene Holdings stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lexagene Holdings is critical whether you are bullish or bearish towards Lexagene Holdings at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lexagene Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Lexagene Holdings Corporate Directors

Lexagene Holdings corporate directors refer to members of a Lexagene Holdings board of directors. The board of directors generally takes responsibility for the Lexagene Holdings' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Lexagene Holdings' board members must vote for the resolution. The Lexagene Holdings board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

Invested in Lexagene Holdings?

The danger of trading Lexagene Holdings is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lexagene Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lexagene Holdings. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lexagene Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Correlation Analysis. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for analysis

When running Lexagene Holdings price analysis, check to measure Lexagene Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexagene Holdings is operating at the current time. Most of Lexagene Holdings' value examination focuses on studying past and present price action to predict the probability of Lexagene Holdings' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexagene Holdings' price. Additionally, you may evaluate how the addition of Lexagene Holdings to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Please note, there is a significant difference between Lexagene Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine Lexagene Holdings value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexagene Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.